TrialHub wins DPHARM Idol Disrupt 2025 with a focus on adapting protocols to patients and accelerating recruitment.
Editorial by Category
Modernizing Clinical Trial Operations
View All
The Trifecta of Protocol Review: Patients, Sites, and Sponsors Building Better Studies
Disruptive Innovations to Modernize Clinical Research: DPHARM 2025 Recap
How Paradigm Health Is Enabling Community and Rural Health Systems to Do Oncology Clinical Research
Three Ways to Help Cut Clinical Trial Timelines in Half: White Paper from McKinsey & Co
Immuno-Oncology and Cell Therapy
View All
Shining a Light on the Immune System to Inform Medicine Development at GSK
MSK on Adding ADCs to Checkpoint Blockade for Bladder Cancer Patients
Immuno-Oncology 360º Announces 2026 Featured Speakers and Key Topics for the 12th Annual Meeting in Boston
Developing Nonactivated CAR T Therapy for Greater Persistence, Reduced Exhaustion and Enhanced In Vivo Expansion
Drug Delivery
View All
Implementing a Control Strategy for Combination Product Design and Manufacturing
Partnering for Combination Product Success: Higher-Level Collaboration that Delivers Higher ROI
Overcoming the Limitations of PLGA-Based Technologies to Enable Better Long-Acting Injectables
Implementing Sustainability Across the Drug Delivery Product Value Chain
Patients as Partners in Clinical Research and Patient Access
View All
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Overcoming Reach and Recruitment Challenges to Engage Rare Disease Patients in Clinical Trials
How Boehringer Ingelheim’s Site Engagement Academy Is Helping to Create Empathetic Site Partnerships for Patient Benefit
Collaborating for Change: Integrating Clinical Trials into Care Pathways
Biotech CMO/R&D Leadership
View All
Community-Based Clinical Trials
View All
Building an Infrastructure to Drive More Effective Patient Enrollment and Retention: Partnerships with Sites Summit 2025 Recap
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Clinical Research as a Care Option: CRAACO 2025 Recap
How Boehringer Ingelheim’s Site Engagement Academy Is Helping to Create Empathetic Site Partnerships for Patient Benefit
Women Leadership in Biotech
View All
Commercializing Therapies Requires Patient-Centricity and Advocacy
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
How Sponsors Can Help Sites with Payment, Staffing and Technology
